SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000903423-16-001327
Filing Date
2016-10-28
Accepted
2016-10-28 16:10:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 glaxo-crspr13d_1027.htm SC 13D 73822
  Complete submission text file 0000903423-16-001327.txt   75272
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478
Type: SC 13D | Act: 34 | File No.: 005-89674 | Film No.: 161958702
SIC: 2836 Biological Products, (No Diagnostic Substances)